1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025

  • June 2015
  • -
  • Future Market Insight Global & Consulting Pvt Ltd
  • -
  • 125 pages

This Future Market Insights report examines the ‘High Content Screening (HCS)’ market for the period 2015–2025. New product launches are resulting in product assortment and thus, increased installation of High Content Screening (HCS) instruments. This is expected to bolster growth of the High Content Screening (HCS) market over the next five to six years. Furthermore, increasing government support for research and development for drug discovery processes across the globe is expected to drive the growth of High Content Screening (HCS) market during the forecast period. Companies are focussing on penetrating untapped markets, such as Asia Pacific and Latin America, where growth of the biotechnology and biopharmaceutical industry is expected to increase significantly.

The High Content Screening (HCS) market report starts with an overview of cell analysis instrumentation market. In addition, this section includes FMI’s analysis of the key trends, drivers and restraints from the supply, demand and economy side, which are influencing the High Content Screening (HCS) market. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in the High Content Screening (HCS) Market report to better equip and arm clients with crystal clear decision-making insights.

The global High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. On the basis of product, the market is segmented as cell imaging and analysis equipment, consumables, software and services. Cell imaging and analysis equipment is further sub-segmented as High Content Screening (HCS) instruments and flow cytometers. Also, High Content Screening (HCS) instruments are categorised into high-end High Content Screening (HCS), mid-end High Content Screening(HCS) and low-end High Content Screening (HCS) instruments. A detailed analysis has been provided for every segment in terms of market size and volume analysis for High Content Screening (HCS) instruments across the globe.

In the next section, FMI covers the High Content Screening (HCS) market performance in terms of application. On the basis of application, the High Content Screening (HCS) market is segmented into primary and secondary screening, target identification and validation, toxicity studies, compound profiling and others. A detailed analysis has been provided for every segment in terms of market size.

Also, FMI provides the High Content Screening (HCS) market analysis of end-use sectors for High Content Screening (HCS). The segmentation includes pharmaceutical and healthcare, biotechnology companies, educational institutions, government organisations and others. A detailed analysis has been provided for every segment in terms of market size.

As highlighted earlier, the High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. All these segments are included in this section to make the study more comprehensive. The subsequent sections provide detailed analysis on the product type, industry and application of the High Content Screening (HCS) market report. The sections provide detailed analysis covering key trends, absolute dollar opportunity and BPS Analysis.

The next section of the report highlights High Content Screening (HCS) adoption by regions. It provides market outlook for 2015–2025 and sets the forecast within the context of the High Content Screening (HCS) ecosystem, including the new technological developments as well as product offerings in the High Content Screening (HCS) market. This study discusses the key region trends contributing to growth of the High Content Screening (HCS) market globally, as well as analyses the degree at which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East and Africa.

All the above sections, by product, by application, by industry or by regions, evaluate the present scenario and the growth prospects of the High Content Screening (HCS) market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the trailing 12 months.

To calculate the High Content Screening (HCS) market size, we have considered revenue generated by the High Content Screening (HCS) manufacturers. The forecast presented here assesses the total revenue by value across the High Content Screening (HCS) market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the High Content Screening (HCS) market will develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the High Content Screening (HCS) market.

As previously highlighted, the High Content Screening (HCS) market is split into a number of segments and sub-segments. All the High Content Screening (HCS) segments in terms of product type, application, industry and regions are analysed in terms of Basis Point Share to understand individual segment’s relative contributions to market growth. This detailed level of information is important for the identification of various key trends of the High Content Screening (HCS) market.

Also, another key feature of this report is the analysis of all key segments and sub-segments in terms of absolute dollar. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the High Content Screening (HCS) market.

Furthermore, to understand key growth segments in terms of growth & adoption of high content screening for cell analysis along with preferred application across the globe in the near future, Future Market Insights developed the High Content Screening (HCS) Market Attractiveness Index. The resulting index should help providers identify real market opportunities.

In the final section of the report, High Content Screening (HCS) Competitive landscape is included to provide report audiences with a Dashboard view, based on categories of provider in the value chain, presence in High Content Screening (HCS) product portfolio and key differentiators. Key categories of providers covered in the report are High Content Screening (HCS) manufacturers. This section is primarily designed to provide clients with an objective & detailed comparative assessment of key providers specific to a market segment in the High Content Screening (HCS) value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and success in High Content Screening (HCS) marketplace. Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the High Content Screening (HCS) space. Key competitors covered in terms of manufacturers are Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex Corporation and Thorlabs Inc.

Table Of Contents

High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025
Table Of Content

1. Research Methodology

2. Assumptions and Acronyms Used

3. Executive Summary

4. Global HCS Market Overview

4.1. Introduction

4.1.1. Global HCS Market: Taxonomy

4.1.2. Global HCS Market: Definition

4.2. Cell Analysis Instrumentation Market Outlook

4.2.1. Cell Analysis Instrumentation Market Size and Forecast

4.3. Global HCS Market Outlook

4.4. Global HCS Market Value and Y-o-Y Growth Forecast

4.5. Global HCS Market Volume and Y-o-Y Growth Forecast

4.6. Global HCS Market Dynamics

4.6.1. Global HCS Market Drivers

4.6.1.1. Economic

4.6.1.2. Demand

4.6.1.3. Supply

4.6.2. Global HCS Market: Restraints

5. Global HCS Market Outlook By Product

5.1. Introduction

5.2. Global HCS Market Value Share and BPS Analysis By Product

5.3. Y-o-Y Growth Comparison By Product

5.4. Cell Imaging and Analysis Instruments

5.4.1. Global HCS Market Value and Y-o-Y Forecast By Cell Imaging and Analysis Equipment

5.4.2. Global HCS Market Value Share and BPS Analysis By Cell Imaging and Analysis Equipment

5.5. Global HCS Market Analysis By Consumables

5.5.1. Global HCS Market Value Share and BPS Analysis By Consumables

5.6. Global HCS Market Analysis By Software

5.6.1. Global HCS Market Value Share and BPS Analysis By Software

5.7. Global HCS Market Analysis By Services

5.7.1. Global HCS Market Value Share and BPS Analysis By Services

5.8. Global HCS Market Attractiveness Analysis By Product

5.9. Global HCS Market Key Trends By Product

6. Global HCS Market Outlook By Application

6.1. Introduction

6.2. Global HCS Market Value Share and BPS Analysis By Application

6.3. Y-o-Y Growth Comparison By Application

6.4. Primary and Secondary Screening

6.4.1. Market Value and Y-o-Y Forecast

6.4.2. Total Opportunity

6.5. Target Identification and Validation

6.5.1. Market Value and Y-o-Y Forecast

6.5.2. Total Opportunity

6.6. Toxicity Studies

6.6.1. Market Value and Y-o-Y Forecast

6.6.2. Total Opportunity

6.7. Compound Profiling

6.7.1. Market Value and Y-o-Y Forecast

6.7.2. Total Opportunity

6.8. Others

6.8.1. Market Value and Y-o-Y Forecast

6.8.2. Total Opportunity

6.9. Global HCS Market Attractiveness Analysis By Application

6.10. Global HCS Market Key Trends By Application

7. Global HCS Market Outlook By Industry

7.1. Introduction

7.2. Global HCS Market Value Share and BPS Analysis By Industry

7.3. Y-o-Y Growth Comparison By Industry

7.4. Pharmaceutical and Healthcare

7.4.1. Market Value and Y-o-Y Forecast

7.4.2. Total Opportunity

7.5. Biotechnology

7.5.1. Market Value and Y-o-Y Forecast

7.5.2. Total Opportunity

7.6. Educational Institutions

7.6.1. Market Value and Y-o-Y Forecast

7.6.2. Total Opportunity

7.7. Independent Contract Research Organisation

7.7.1. Market Value and Y-o-Y Forecast

7.7.2. Total Opportunity

7.8. Government Organisation

7.8.1. Market Value and Y-o-Y Forecast

7.8.2. Total Opportunity

7.9. Others

7.9.1. Market Value and Y-o-Y Forecast

7.9.2. Total Opportunity

7.10. Global HCS Market Attractiveness Analysis By Industry

7.11. Global HCS Market Key Trends By Industry

8. Global HCS Market Outlook By Regions

8.1. Introduction

8.2. Global HCS Market Value Share and BPS Analysis By Regions

8.3. North America HCS Market Value and Y-o-Y Growth Forecast

8.3.1. North America HCS Market Value Share and BPS Analysis By Product

8.4. Latin America HCS Market Value and Y-o-Y Growth Forecast

8.4.1. Latin America HCS Market Value Share and BPS Analysis By Product

8.5. Western Europe HCS Market Value and Y-o-Y Growth Forecast

8.5.1. Western Europe HCS Market Value Share and BPS Analysis By Product

8.6. Eastern Europe HCS Market Value and Y-o-Y Growth Forecast

8.6.1. Eastern Europe HCS Market Value Share and BPS Analysis By Product

8.7. Asia Pacific Excluding Japan (APEJ) HCS Market Value and Y-o-Y Growth Forecast

8.7.1. APEJ HCS Market Value Share and BPS Analysis By Product

8.8. Japan HCS Market Value and Y-o-Y Growth Forecast

8.8.1. Japan HCS Market Value Share and BPS Analysis By Product

8.9. MEA HCS Market Value and Y-o-Y Growth Forecast

8.10. MEA HCS Market Value Share and BPS Analysis By Product

8.11. Global HCS Market Key Trends By Regions

9. Competitive Landscape

9.1. Company Dashboard

9.2. Company Profiles

9.2.1. Becton, Dickinson and Company

9.2.2. Thermo Fisher Scientific Inc.

9.2.3. GE Healthcare

9.2.4. Olympus Corporation

9.2.5. PerkinElmer Inc.

9.2.6. Merck Millipore Corporation

9.2.7. Danaher Corporation (Molecular Devices)

9.2.8. Yokogawa Electric Corporation

9.2.9. Sysmex Corporation

9.2.10. Thorlabs, Inc.

10. Key Comments by Industry Experts

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.